Page last updated: 2024-11-02

moxonidine and Injury, Myocardial Reperfusion

moxonidine has been researched along with Injury, Myocardial Reperfusion in 2 studies

moxonidine: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"The aim of the present study was to investigate the influence of moxonidine, a representative of I1-imidazoline-receptor agonist, on arrhythmias induced by myocardial ischemia or reperfusion."7.69Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion. ( Leprán, I; Papp, JG, 1994)
"The aim of the present study was to investigate the influence of moxonidine, a representative of I1-imidazoline-receptor agonist, on arrhythmias induced by myocardial ischemia or reperfusion."3.69Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion. ( Leprán, I; Papp, JG, 1994)
"Moxonidine has been shown to be antiarrhythmic during ischaemia in vivo."1.30Facilitation of spontaneous defibrillation by moxonidine during regional ischaemia in an isolated working rabbit heart model. ( Cobbe, SM; Hicks, MN; Kane, KA; Wolk, R, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leprán, I1
Papp, JG1
Wolk, R1
Kane, KA1
Cobbe, SM1
Hicks, MN1

Other Studies

2 other studies available for moxonidine and Injury, Myocardial Reperfusion

ArticleYear
Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion.
    Journal of cardiovascular pharmacology, 1994, Volume: 24 Suppl 1

    Topics: Analysis of Variance; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Coronary Vessels; Dise

1994
Facilitation of spontaneous defibrillation by moxonidine during regional ischaemia in an isolated working rabbit heart model.
    European journal of pharmacology, 1999, Feb-12, Volume: 367, Issue:1

    Topics: Action Potentials; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Disease Models, Animal; E

1999